We further studied the effect of atorvastatin on the expression of MMP9, MMP12, CD36, and FABP4 in A549 cells in order to explore the possible underlying mechanism of atorvastatin inhibiting the migration of NSCLC. The gene discussed is CD36; the disease is non-small cell lung carcinoma.